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Abstract
Background: Peptidergic neurons store and secrete the contents of large dense core vesicles (LDCVs) from axon
terminals and from dendrites. Secretion of peptides requires a highly regulated exocytotic mechanism, plus
coordinated synthesis and transport of LDCVs to their sites of release. Although these trafficking events are critical
to function, little is known regarding the dynamic behavior of LDCVs and the mechanisms by which their transport
is regulated. Sensory neurons also package opiate receptors in peptide-containing LDCVs, which is thought to be
important in pain sensation. Since peptide granules cannot be refilled locally after their contents are secreted, it is
particularly important to understand how neurons support regulated release of peptides.
Results: A vector encoding soluble peptidylglycine a-hydroxylating monooxygenase fused to green fluorescent
protein was constructed to address these questions in cultured primary peptidergic neurons of the trigeminal
ganglion using time lapse confocal microscopy. The time course of release differs with secretagogue; the secretory
response to depolarization with K
+ is rapid and terminates within 15 minutes, while phorbol ester stimulation of
secretion is maintained over a longer period. The data demonstrate fundamental differences between LDCV
dynamics in axons and growth cones under basal conditions.
Conclusions: Under basal conditions, LDCVs move faster away from the soma than toward the soma, but fewer
LDCVs travel anterograde than retrograde. Stimulation decreased average anterograde velocity and increases
granule pausing. Data from antibody uptake, quantification of enzyme secretion and appearance of pHluorin
fluorescence demonstrate distributed release of peptides all along the axon, not just at terminals.
Background
Communication within the nervous system relies on the
stimulus-dependent release of neurotransmitters from
vesicles. Neurons contain two vesicle classes competent
for regulated exocytosis: small synaptic vesicles (SSVs)
and large dense core vesicles (LDCVs, also referred to
as secretory granules). Different stimuli regulate secre-
tion from SSVs and LDCVs. Unlike neuropeptide-con-
taining LDCVs, SSVs contain low molecular weight
neurotransmitters synthesized in the cytosol [1]. Newly
synthesized membrane proteins of SSVs are transported
separately to the nerve terminal where they are incorpo-
rated into SSVs. Biogenesis and recycling of SSVs at the
nerve terminal are closely coupled, since formation may
arise from a presynaptic endosomal compartment or
directly from the plasma membrane, controlling the
ability of neurons to react rapidly to stimulation and
sustain neurotransmitter release [2].
In contrast to synaptic vesicles, LDCVs contain pep-
tides synthesized as inactive precursors into the endo-
plasmic reticulum and transported to the trans-Golgi
network, to be packaged into immature LDCVs and
transported down the axon [3]. These LDCVs undergo a
series of maturation steps, transforming them into regu-
lated exocytotic carriers. This biosynthetic pathway pre-
cludes local refilling, but LDCVs may engage in
incomplete discharge of their contents [4]. LDCVs also
deliver integral membrane proteins such as opiate recep-
tors and ion channels to the cell surface in a regulated
manner [5-9].
Little is known regarding the dynamic behavior of
LDCVs and the mechanisms by which their transport is
regulated in neurons. Most previous studies have uti-
lized neuroendocrine cells such as PC12 or chromaffin
cells, which preludes the analysis of events that occur
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short-range motions of LDCVs in developing hippocam-
pal neurons to their motions in neuroendocrine cells
has demonstrated differences; the immobile fraction of
LDCVs in neurons is smaller, and mobile LDCVs parti-
cipate in exocytosis [11], while chromaffin LDCVs are
usually immobile for several seconds before secretion
[4].
Several lines of evidence suggest that LDCV mobility
is responsive to secretagogue stimulation. In neuronally
derived NS20Y cells, LDCV velocity is increased by for-
skolin but not by high K
+ [12]. At the Drosophila neuro-
muscular junction, mobilization of synaptic peptidergic
LDCVs occurs following a depolarizing stimulus inde-
pendent of axonal transport motors or F-actin polymeri-
zation [13]. Moreover, after synaptic peptide content has
been depleted, neuropeptide stores are replenished in en
passant terminals using retrogradely transiting LDCVs,
not anterograde LDCVs [14].
The trigeminal ganglion contains primary afferent
neurons which relay sensory information from craniofa-
cial tissues. These neurons have axons but not den-
drites. In vivo, 40-50% of these neurons contain
calcitonin gene related peptide (CGRP); a subpopulation
(20%) of these CGRP-positive neurons also express sub-
stance P [15]. These peptides have been implicated in
the transmission of nociceptive information [16]. When
dissociated trigeminal ganglion neurons are cultured in
the presence of nerve growth factor (NGF), the majority
show a peptidergic phenotype. NGF both supports sur-
vival of these neurons [17] and causes an increase in
peptide expression [18].
LDCV dynamics in neurons have been described as
either diffusive or directed, with mobilities that vary
over a wide range [11]. However, these studies have not
differentiated between LDCVs in transit versus those at
exocytotic sites. Using primary trigeminal ganglion neu-
rons as a model peptidergic system, we first sought to
describe the dynamic behavior of LDCVs under basal
conditions. We compared the behavior of LDCVs in
growth cones to those in the distal portion of axons
adjacent to the growth cone. We evaluated the effects of
two different secretagogues on transport dynamics,
including both cumulative and instantaneous para-
meters. Secretion was assessed by expressing a fluores-
cently tagged LDCV enzyme.
Methods
Constructs
The expression vector encoding peptidylglycine
a-hydroxylating monooxygenase (PHM) has been
described [19]. PAM-2-GFP was constructed in pEGFP-
N2 (Clontech) by fusing in-frame the COOH-terminal
of PAM (...PAPSS
976) at an engineered SmaI site,
incorporating the short intervening linker derived from
pEGFP-N2 (PGIHRPVAT), followed by the N-terminus
of EGFP (M
1VSKG...). Constructs were verified by DNA
sequencing.
To construct a vector encoding PHM-pHluorin,
pHluorin was isolated from synaptopHluorin (gift from
Dr. G. Miesenbock) by PCR. The sense primer was
5’-TATAAT GAATTC ATGAGCGGAAGCGGCGG-
GACCGGT-3’ (adding EcoRI site italics); the antisense
primer was 5’-ATATATAT GCGGCCGC AGAT-
TAACCGGT TTTGTATAG-3’ (adding NotI).
T h eP C Rp r o d u c ta n dt h ep E G F P - N 2v e c t o rw e r e
both digested with EcoRI and NotI; the pHluorin insert
was ligated into the vector, replacing EGFP (now
referred to as p.pHluorin-N2). The reading frame was
then corrected using the Stratagene QuickChange
method of site-directed deletion mutagenesis with the
sense primer 5’-CTGCTAGGAGAAAGGGAAGAA-
TTCATGAGCGGAAG-3’ and antisense primer 5’-
CTTCCGCTCATGAATTCTTCCCTTTCTCCTAG-
CAG-3’. Next, PHM was removed from the pBluescript
PAM-1 vector by digestion with XmnI and HindIII. The
PHM fragment was inserted into the p.pHluorin-N2
vector digested with EcoRI, blunted with Klenow,
followed by HindIII digestion, yielding PAM-1 residues
1-407 fused in reading frame with pHluorin. The con-
struct was verified by DNA sequencing.
Cell culture and transfections
Trigeminal ganglia were dissected from P3-P5 Sprague
Dawley rat pups, digested sequentially in collagenase
and trypsin, and mechanically triturated to create a sin-
gle cell suspension. Cells were passed through a 70 μm
nylon cell strainer, and resuspended in 3 ml L15 con-
taining 1 mg/ml fatty acid free bovine serum albumin
(BSA). This suspension was layered on top of 6 ml L15
containing 10 mg/ml BSA, centrifuged at 100 × g for 3
minutes, and the supernatant removed. This density gra-
dient and centrifugation procedure was repeated to
enrich cultures for neurons. The final cell pellet was
either resuspended in L-15 growth medium (containing
10% fetal calf serum, 50 ng/ml nerve growth factor
[NGF, BD Biosciences], 50 mM glucose, 250 μMa s c o r -
bate, and 8 mM glutathione) or in Rat Neuron Nucleo-
fector solution (Amaxa). For nucleofection, the cell
suspension was added to 10-12 μg DNA (for approxi-
mately 24-28 ganglia) and program G-13 was used with
the Nucleofector II. Cells were resuspended in growth
medium, and plated onto collagen coated 0.17 mm glass
coverslips or 4 well plastic culture dishes.
Immunocytochemistry
After 1-3 days in culture, cells were fixed in 4% formal-
dehyde in PBS, permeabilized in 0.075% Triton X-100 in
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with primary antibody overnight at 4°C. Antibodies used
were rabbit anti-CGRP (MU33, 1:2000, gift from Dr. Ian
Dickerson), guinea pig anti-substance P (1:1000, Neuro-
mics), and mouse anti-bIII tubulin (TUJ1, 1:5000, Cov-
ance). Cells were rinsed 3 times with PBS, then
incubated for 1 hour with secondary antibody conju-
gated to FITC, Cy3 (Jackson Immunoresearch), or Alexa
Fluor 633 (Invitrogen). Staining was visualized using a
Zeiss LSM510 confocal microscope in the Center for
Cell Analysis and Modeling (University of Connecticut
Health Center).
Live cell imaging
Live neurons were imaged in L-15 without phenol red
a n dm a i n t a i n e da t3 0 ° Cw i t haB i o p t e c h sD e l t a Te n v i r -
onmental control system. Imaging was performed on a
Perkin Elmer Ultraview spinning disk confocal micro-
scope, with image acquisition by ImageSuite software.
Selective photobleaching was done using a Photonics
Micropoint Mosaic digital diaphragm system. Z-stacks
of 5 μm thickness (0.3 μmi n t e r v a l s )w e r ea c q u i r e dc o n -
tinuously (1.7 sec/stack, 2 × 2 binning) for 5 minutes
under basal conditions, during stimulation with 1 μM
phorbol 12-myristate 13-acetate (PMA) or with 50 mM
KCl. This mode of imaging allowed tracking LDCVs for
greater distances along the axons, moving up and down
with respect to the tissue culture dish. It does place an
upper limit of ~0.4 μm/sec on LDCV velocity for the
tracking software to recognize the same LDCV (4 pixels
in 1.7 sec). Visual inspection would have identified
LDCVs moving faster than 0.5-1 μm/sec and none were
seen.
To image exocytosis of PHM-pHluorin, transfected
neurons were maintained at 35°C with a Zeiss stage hea-
ter, and lines scans were continuously recorded in the
presence of secretagogue in line scanning mode with a
Zeiss LSM 510 confocal microscope. The line selected
for imaging was oriented so that it ran through the cen-
ter of both an axon and a growth cone. The focal plane
chosen for imaging was at the interface of the cell and
coverslip. For these experiments, neurons were co-trans-
fected with PHM-pHluorin (8 μgD N A )a n dp D s R e d -
Monomer (1 μg, Clontech) to facilitate identification of
transfected cells; expression of PHM-pHluorin was veri-
fied at the conclusion of the experiment via addition of
5m MN H 4Cl to the medium.
Image analysis
Maximum-intensity projections were generated from z-
stacks and used for motion tracking analysis. An auto-
mated workfile was created to identify and track indivi-
dual LDCVs in sequential frames using the Simple PCI
motion tracking module (Compix). Identification
involved passing images through a smoothing filter and
setting an intensity threshold. Selected objects that
appeared to be touching each other were separated, and
inclusion criteria for area and roundness set identically
for all image sequences. Centroid X and Y positions
were calculated by the software to produce coordinates
for each object in every image frame in which it was
identified. Any object tracked for less than 7 frames was
excluded from further analysis. Tracks were initially ver-
ified manually by checking that the center of gravity as
defined by the software corresponded to the same
LDCV at each timepoint throughout its trajectory. Velo-
city, direction, linearity, and processivity were then cal-
culated for each LDCV being tracked. Velocity, direction
and linearity for a whole run (several time points) were
taken from the Simple PCI analysis. For instantaneous
velocity and direction, the X-Y coordinates for each
time point were used to calculate distance traveled in
the time bin (hence instantaneous velocity) and the X
and Y movements were used to calculate direction
(0-360°). The definition of anterograde/retrograde was
made using images of the axon or ending being studied.
Antibody internalization
Neurons expressing PAM-GFP were incubated with
PHM antibody (JH1761, 1:100) [19] for 15 minutes in
basal medium or during stimulation with 1 mM PMA
or 50 mM KCl. Cells were rinsed, fixed in 4% formalde-
hyde, and processed for immunocytochemistry as
describe above.
Secretion experiments and enzyme assays
Cells were rinsed 3 times with pre-warmed L-15, collec-
tions were made of basal secretion, followed by stimula-
tion with 1 μM PMA or 50 mM KCl in L-15 (5, 15, or
30 minutes each) made by mixing L-15 with isotonic
150 mM KCl. When indicated, temperature was used as
a variable and cells were kept at either room tempera-
ture or above 30°C for the duration of the experiment.
Medium was centrifuged to remove non-adherent cells,
and protease inhibitors added. Cells were harvested in
20 mM Na-N-Tris [hydroxymethyl]methyl-2-aminoetha-
nesulfonic acid (TES), 10 mM mannitol, and 1% Triton
X-100, pH 7.4 (TMT) with protease inhibitors [19],
extracts were frozen and thawed three times and centri-
fuged to remove debris. Cell extracts and media samples
were analyzed for PHM secretion by enzyme assay using
125I labeled a-N-acetyl-Tyr-Val-Gly as substrate [20].
Samples were assayed in triplicate, and reactions were
carried out for 3 hours.
Statistics
Statistical analyses were performed using SPSS (PASW
17.0).
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Use of PHM-GFP to monitor trigeminal ganglion
neuron peptidergic LDCVs
In order to investigate the dynamic behavior of LDCVs
in living neurons, we utilized a primary culture system
of trigeminal ganglion neurons (Figure 1). In our culture
conditions, immunocytochemical analysis showed that
greater than 95% of b III tubulin-positive neurons
expressed either CGRP [21] or substance P or both
(Figure 1). Since nociceptive neurons can be identified
by their small soma size (diameter < 25 μm), all neurons
analyzed met this criterion.
The soluble secretory protein PHM-GFP is efficiently
targeted to LDCVs in endocrine cells [19] and was
therefore expressed in trigeminal ganglion neurons. The
fusion protein localized to puncta distributed through-
out the cell soma and axonal processes. Simultaneous
visualization of endogenous CGRP (Figure 2A) or sub-
stance P (not shown) revealed substantial colocalization.
LDCVs accumulated at a higher density in growth cones
(Figure 2B, green), which are the site at which regulated
release is generally studied. Growth cones contained a
large amount of filamentous actin (Figure 2B, red),
w h i l em i c r o t u b u l e sw e r em o r ep r e v a l e n ti na x o n s
(Figure 2B, blue).
Localization of PHM-GFP to the regulated secretory
pathway was confirmed by quantifying basal and stimu-
lated secretion. We chose two secretagogues with differ-
ent mechanisms of action for our studies. An increase
in KCl depolarizes the cells, potentially triggering action
potential initiation, and opens voltage-gated calcium
channels to increase secretion in a Ca
++-dependent
manner. Application of phorbol myristate acetate (PMA)
activates Protein Kinase C, which phosphorylates various
components of the SNARE complex as well as ion chan-
nels, causing secretion [22]. In order to select an appro-
priate temperature for our imaging experiments, we
evaluated the effect of temperature on basal and stimu-
lated secretion. Basal secretion of PHM-GFP was similar
at 23°C (room temperature) and at 30°C (Figure 2C).
Basal secretion from AtT-20 cells releases processed
products from LDCVs, but is not dependent on calcium
Figure 1 Trigeminal ganglion neurons are peptidergic. Trigeminal ganglia from P3-P5 rat pups were dissociated and maintained in culture
for 2 days. Cells were fixed and processed for immunocytochemistry using antibodies to CGRP (green), substance P (red), and bIII tubulin (blue).
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perature doubled the secretion rate, raising the tempera-
ture to 30°C resulted in a further three-fold increase in
PHM-GFP secretion, to 8% of cell content in 30 min-
utes. A similar effect of temperature on stimulated
secretion was observed when pituitary cells were evalu-
ated (Eipper & Mains, unpublished). Since regulated
secretion was greatly dimini s h e da tr o o mt e m p e r a t u r e ,
all of our LDCV tracking data were from cultures main-
tained at or slightly above 30°C.
To select the time period over which LDCV motion
was evaluated, we quantified secretion of PHM-GFP for
5 to 30 minutes following application of basal medium
or medium containing KCl or phorbol ester at 37°C
(Figure 2D). Stimulated secretion was calculated by sub-
tracting basal from total secretion (blue minus red =
gray line). Both PMA and KCl stimulated secretion of
PHM within 5 minutes. PMA-stimulated secretion per-
sisted for the duration of the experiment, while KCl-sti-
mulated secretion occurred primarily within 5 minutes
and was completed by 15 minutes. After 30 minutes at
37°C, both PMA and KCl had stimulated the secretion
of about 15% of the total cell content of PHM-GFP, a
larger percentage than observed at 30°C. Based on these
experiments, LDCV movement was evaluated in neurons
maintained at or above 30°C and data were accumulated
within the first 5 minutes after secretagogue application.
LDCV dynamics in axons and growth cones differ under
basal conditions
The dynamics of LDCVs were first characterized under
basal conditions. Dissociated trigeminal ganglion neu-
rons were transfected with vector encoding PHM-GFP,
and imaging experiments performed 24-48 hours later.
Figure 2 Expression of PHM-GFP allows quantification of LDCV dynamics and secretion. (A) Dissociated trigeminal ganglion neurons were
transfected with vector encoding PHM-GFP and grown in culture for 2 days. Cells were fixed and processed for immunocytochemistry; PHM-GFP
fluorescence was visualized in puncta throughout the cell soma and processes (green) along with CGRP (red). (B) A growth cone (labeled) and
the preceding region of its axon are shown with immunofluorescent staining of CGRP (green) and bIII tubulin (blue); filamentous actin was
visualized with a fluorescent phalloidin conjugate (red). F-actin enriched stress fibers in a non-neuronal cell are seen at the bottom of the image.
(C) Duplicate cultures were analyzed at room temperature (23°C) and at 30°C; 30 minute medium collections were made under basal conditions
and during stimulation with 1 μM PMA. Secretion was quantified by measuring units of PHM activity (pmol product/h) in basal and stimulated
media and in cell extracts. (D) Cultures were stimulated for 5, 15, or 30 minutes at 37°C with 1 μM PMA or 50 mM KCl. Secretion was quantified
by assaying units of PHM activity in basal and stimulated media; stimulated secretion was calculated by subtracting basal from total secretion
(gray line); separate experiments with cultures of different densities were performed for PMA and KCl.
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occurred rapidly and growth cones were abundant. The
short time made it possible to identify the cell soma
associated with the growth cone chosen for imaging and
distinguish anterograde from retrograde trafficking.
Growth cones of small diameter neurons containing
fluorescent LDCVs were identified, and the entire
growth cone and the axonal segment immediately pre-
ceding it were imaged. Selective photobleaching of axo-
nal segments was performed to facilitate LDCV tracking.
Z-stacks were acquired continuously and maximum-
intensity projections were generated for tracking analy-
sis. Trajectories were generated for all tracked LDCVs
based on the coordinates at each point in time; sample
trajectories for two LDCVs that displayed different types
of behavior are shown (Figure 3A).
LDCV #219 moved in a rapid and directed manner
without changing direction, while LDCV #235 demon-
strated slow, dithering motion, with frequent changes in
direction. The tracking protocol was validated by manu-
ally comparing the trajectories with the actual LDCV
motion in several time lapse image sets. In order to dis-
tinguish directed from diffusive motion, we used the
method of Steyer and Almers to calculate diffusion con-
stants (D) [26] for these vesicles. For the rapidly moving
LDCV (#219), D is greater than 1000 × 10
-4 μm
2/sec;
for the dithering LDCV (#235), D = 95 × 10
-4 μm
2/sec.
For LDCVs diffusing freely in the cytosol, D = 10 × 10
-4
μm
2/sec [26]. Polystyrene beads the size of LDCVs have
comparably small diffusion coefficients when studied in
viscous media [27,28]. Thus the majority of the move-
ments we are observing are not due to diffusion.
Velocity, linearity, and direction were quantified for
basal analysis of LDCVs in axons compared to growth
cones. Velocity data of identified LDCV trajectories in
growth cones and distal portions of axons were pooled
from 6 cells each. Calculation of velocity was done as an
average for the entire trajectory of each LDCV analyzed.
The distribution of binned data is shown in the histo-
gram (Figure 3B), with the cumulative plot (Figure 3C)
emphasizing the differences between the two regions.
For a given speed on the x-axis of the cumulative velo-
city plot, the associated fraction on the y-axis gives the
fraction of LDCVs moving at, or below, that speed.
Under basal conditions, axons contained a subpopula-
tion of LDCVs traveling with greater velocities than
those observed in growth cones (p < 0.05, n = 227;
marked by asterisks). These LDCVs moved with speeds
greater than 0.1 μm/sec. Statistical significance was
assessed using the Kolmogorov-Smirnov test [29].
Figure 3 LDCV dynamics in growth cones and axons are fundamentally different under basal conditions. For analysis under basal
conditions, neurons were kept in phenol-free L15 medium at or above 30°C. LDCVs containing PHM-GFP were tracked in growth cones and
distal portions of axons. Examples of X-Y LDCV trajectories are shown; one showed rapid, directed motion (#219), and the other moved in a
slow, dithering manner (#235). Velocity data for identified LDCV trajectories were pooled from 6 cells. The distribution of binned data is shown in
the histogram (B), with the cumulative plot (C) emphasizing the differences between the two regions. LDCV trajectories were also analyzed to
determine the distribution of linearity (D). Linearity was calculated by comparing how close the actual path was to a straight line representing
the distance between the first and last point tracked. Cumulative direction was analyzed based on the mean angle of the trajectory (E) and
assigned a score of 1 if anterograde or 0 if retrograde. N = 2760 LDCVs tracked.
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estimated due to the time required for the z-stack ima-
ging, but such fast LDCVs were not detected by visual
inspection.
LDCV trajectories were further analyzed to determine
the distribution of linearity. Linearity was calculated by
comparing how close the actual path was to a straight
line representing the distance between the first and last
point, so that a maximum linearity score is 1.00. As
expected, the cumulative plot showed that LDCV tracks
in axons were more linear than LDCV tracks in growth
cones (p < 0.025, n = 227; marked by bracket)
(Figure 3D).
The net direction of LDCV movement was determined
based on the average angle of each trajectory. A score of
0 was assigned for a net angle representing retrograde
movement (toward the cell body), and a score of 1 for
movement in the anterograde direction (directed toward
the ending). Cumulative directionality scores for LDCVs
in axons and growth cones did not differ significantly
(Figure 3E). In growth cones, LDCVs moved in both
directions with approximately equal frequencies. To our
surprise, retrograde transport was slightly favored in the
axon.
An intact actin cytoskeleton is required for efficient
LDCV transport
The lack of directionality in growth cones as compared
to axons could be related to detachment of motor pro-
teins upon entry into growth cones, and to a prevalence
of actin over microtubules. We tested whether an intact
cytoskeleton were required for efficient LDCV transport
by pharmacological disruption of filamentous actin with
cytochalasin B. Filamentous actin was visualized using a
fluorescent phalloidin conjugate, verifying that cytocha-
lasin treatment resulted in the rearrangement of F-actin
into puncta (Figure 4A, red); microtubules were unaf-
fected (Figure 4A, green). The effect of cytochalasin
treatment on LDCV dynamics was assessed; both cumu-
lative velocity (p < 0.05) (Figure 4B) and cumulative lin-
earity (p < 0.005) (Figure 4C) were reduced following F-
actin depolymerization. Cytochalasin treatment did not
have an effect on trajectory direction (not shown). The
response observed may reflect a role for LDCV-asso-
ciated filamentous actin in normal transport or an inhi-
bitory effect of depolymerized actin, and further
strengthens our conclusion that the movements
observed are not diffusive.
Effects of secretagogue stimulation on cumulative
trajectory parameters
In addition to stimulating exocytosis, we hypothesized
that secretagogue might regulate LDCV transport, per-
haps by increasing directed transport to sites of
exocytosis and/or initiating signaling events required to
retrieve membrane components for recycling. Analysis
of LDCV trafficking in axons during exposure to PMA
or KCl was performed as described for basal conditions
(Figure 3); data for each treatment group were pooled
from 6 cells each. The distribution of cumulative veloci-
ties is shown for LDCVs during basal conditions and
during stimulation with PMA and KCl (Figure 5A). Fig-
ure 5 shows that 100% of LDCVs move at speeds of 0.4
μm/sec or slower; from the plot, about half the LDCVs
move at 0.025 μm/sec or slower, which may represent
simple diffusion (D = 6 × 10
-4 μm
2/sec). Neither drug
had a significant effect on overall LDCV velocity. When
linearity was analyzed (Figure 5B), both PMA (p < 0.01,
n = 223) and KCl (p < 0.005) were seen to reduce the
fraction of LDCVs exhibiting low linearity of motion.
Effects of secretagogue stimulation on instantaneous
trajectory parameters
Since the rapidly changing behavior of LDCVs was not
reflected by cumulative measurements, we next assessed
the effects of secretagogue on instantaneous velocity and
direction. To do this, axons from three neurons were
analyzed under basal conditions and after stimulation
with KCl or PMA; velocity and direction were calculated
for each time point (1.7 sec/stack) in the trajectory using
individual LDCV coordinates. The histogram in
Figure 6A shows the distribution of instantaneous velo-
cities for each condition; within each group there was
no statistically significant difference between axons.
LDCVs moving in the retrograde direction were
assigned a negative sign, while those moving in the ante-
rograde direction were assigned a positive sign. LDCVs
moving less than one pixel in 1.7 sec (<0.08 μm/sec)
were categorized as paused.
The overall effect of secretagogue on instantaneous
direction is displayed as an average for each treatment
condition (Figure 6B). Under basal conditions, a larger
fraction of LDCVs moved in the retrograde direction
than in the anterograde direction and less than 10% of
the LDCVs were classified as paused. Stimulation with
either secretagogue increased the fraction of LDCVs cate-
gorized as paused, perhaps corresponding to an “immo-
bile” fraction of LDCVs eligible for release. Stimulation
with KCl also resulted in a shift from retrograde to ante-
rograde transiting LDCVs (Figure 6B). Since LDCVs were
tracked for 5 min or less, secretion was not sufficient to
bias calculations of directionality (Figure 2).
Next, we analyzed the relationship between direction
and velocity for each time interval (Figure 6C). LDCVs
are transported away from the cell soma at a signifi-
cantly faster rate than those traveling towards the cell
soma under basal conditions. For those LDCVs under-
going retrograde transit, KCl increased instantaneous
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but reduced the average instantaneous velocity of ante-
rograde LDCVs to half of that observed under basal
conditions (Figure 6C). In contrast to its effect of
LDCVs undergoing retrograde transport, KCl dimin-
ished the velocity of LDCVs traveling anterograde.
PMA stimulation increases LDCV pausing
To be fully or partially secreted, a LDCV must pause or
stop, at least momentarily [26,30]. We therefore looked
more closely at the pausing behavior of individual
LDCVs. The effect of secretagogue on the percentage of
time any given LDCV spent paused vs. moving was
determined; data were plotted both as a histogram (Fig-
ure 7) and as a cumulative plot (not shown). The indivi-
dual coordinates of LDCVs at each timepoint in the
trajectory were used for this calculation. If the
coordinates remained identical for two consecutive
timepoints, the LDCV was counted as “paused.” Under
basal conditions, approximately 30% of the LDCVs
moved continuously, with no pauses observed. Exposure
to PMA decreased the fraction of LDCVs that moved
continuously three-fold, to 10% (p < 0.005). In contrast,
KCl was without significant effect on the percentage of
time a LDCV spent paused. This result is consistent
with the ability of PMA to restrict the mobility of
LDCVs, which in turn correlates with an increase in
priming [31].
LDCV fusion events occur along axons and in growth
cones
More frequent stopping of LDCVs in axons is suggestive
of docking and fusion events occurring along the length
of the axon. To assess this possibility we used an
Figure 4 An intact actin cytoskeleton is required for efficient LDCV transport. Trigeminal ganglion neurons were treated with 5 μM
cytochalasin B for 1 hour and then fixed and processed for immunocytochemistry (A). Filamentous actin was visualized by staining with a TRITC-
phalloidin conjugate (red) and microtubules were stained with an antibody to bIII tubulin (green). Inset: phalloidin staining is shown at higher
magnification to illustrate puncta that appeared in cytochalasin-treated neurons. Neurons expressing PHM-GFP were pretreated with cytochalasin
B in the same manner before live imaging; cumulative velocity (B) and cumulative linearity (C) were plotted as in Figure 3.
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Page 8 of 15antibody to the luminal domain of a LDCV membrane
enzyme, PAM. Internalized antibody was subsequently
visualized in fixed cells with a Cy3 conjugated secondary
antibody. To increase the signal obtained, PAM-GFP
was expressed in trigeminal neurons; PAM-GFP was
visible in tubulovesicular structures in the cell soma and
in vesicular structures throughout axonal processes (Fig-
ure 8, left). Under basal conditions, antibody uptake was
barely detectable (not shown). When PMA was added to
the cultures, uptake of PAM ectodomain antibody was
readily assessed; internalized PAM antibody was present
in vesicular structures throughout the cell soma (Fig-
ure 8, top), along axonal processes and at growth cones
(Figure 8, bottom). Internalized antibody (red) was seen
in a subset of the PAM-GFP LDCVs (yellow arrows),
while other PAM-GFP LDCVs did not contain detect-
able antibody (green arrows). Uptake was also stimu-
lated by KCl (not shown).
Since this approach did not permit direct visualization
of fusion events in real time, we constructed a vector
encoding PHM fused to pHluorin, a pH sensitive
mutant of GFP [32]. Neurons were co-transfected with
vectors encoding PHM-pHluorin and DsRed to enable
identification of transfected cells (Figure 9A). Under
basal conditions, the fluorescence of PHM-pHluorin is
quenched by the acidic interior of the LDCVs, and is
apparent only upon alkalinization (Figure 9B, green,
right). We reasoned that LDCV release would be detect-
able as PHM-pHluorin was released from LDCVs that
fused with the plasma membrane [32]. Diffusion of the
secreted PHM-pHluorin would be expected to produce
a transient increase in fluorescence at release sites.
In order to detect release of PHM-pHluorin, a hori-
zontal line was placed through the center of the axon
and growth cone (Figure 9A, right), and was continu-
ously scanned during secretagogue stimulation. The
transient appearance of green fluorescent streaks pre-
sumably correlates with individual sites of exocytosis,
since the fluorescence should be visible only when the
pHluorin is near neutral pH, during LDCV fusion and
secretion; sample recordings during PMA stimulation
are shown (Figure 9C). Each of these events occurred in
a different location. The event shown in the left panel
occurred in the growth cone between 1 and 2 seconds
into the recording, while the event in the center panel
occurred in the axon over a 2 second period later in the
session. Following image acquisition, NH4Cl was added
to the medium in order to visualize the total LDCV
population containing PHM-pHluorin (Figure 9C, right).
The line scan data acquired after addition of NH4Cl
showed stabilization of PHM-pHluorin fluorescence
over time, as expected; LDCVs were more prevalent in
growth cones than in the axon. Based on both antibody
uptake experiments and direct visualization of secretion,
LDCVs are released from axons and growth cones. In
five neurons recorded in detail using line scans, the vast
majority of the fluorescence events (presumptive secre-
tion) occurred in axons, not in endings/growth cones.
Discussion
Advantages of the trigeminal ganglion culture system
for studying LDCV mobility
Our analysis of LDCV dynamics took a novel approach
by utilizing primary neurons specialized to produce high
levels of neuropeptides. Secretion of peptides such as
C G R Pa n ds u b s t a n c ePf r o md o r s a lr o o ta n dt r i g e m i n a l
ganglion neurons is an essential component of the
transmission of nociceptive stimuli and contributes to
peripheral inflammatory responses. In addition, these
LDCVs deliver opiate receptors to the cell surface and
may be involved in opiate receptor internalization as
well [5]. Unlike neuroendocrine cell lines, sensory
Figure 5 Secretagogues increase linearity but not cumulative
velocity in axons. LDCVs containing PHM-GFP were imaged in the
presence of PMA or KCl; the effects of secretagogue on dynamics
were compared to behaviors observed under basal conditions. LDCV
velocity and linearity were assessed in axons; data for each treatment
group were pooled from 6 cells each. The distribution of cumulative
velocity (A) and linearity (B) is shown for LDCVs under basal
conditions and during stimulation with PMA and KCl. Both PMA and
KCl had a significant effect (p < 0.01) on linearity, but not on velocity.
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Page 9 of 15neurons such as trigeminal ganglion neurons must be
equipped to transport LDCVs over long distances to
reach their target tissues, both centrally and peripher-
ally. The speed with which these neurons extend long,
straight processes makes them especially useful for
in vitro trafficking studies.
LDCV mobility is essential for sustaining the secretory
response at distant sites of release. New LDCVs must
come from the cell soma, the only site at which prepro-
neuropeptides are synthesized and packaged into
LDCVs. Since trigeminal ganglion neurons released 15%
of their cell content during a 30 minute exposure to
PMA or KCl, we hypothesized that these secretagogues
would alter LDCV transport. We first compared LDCV
transport in axons and growth cones. Differences were
expected since long distance movements must occur in
axons and secretion is generally assumed to occur at
terminals.
Under basal conditions, LDCVs in axons moved with
greater average velocities than LDCVs in growth cones.
LDCVs moving with average velocities greater than 0.1
μm/second were seen only in axons; these rapidly moving
LDCVs accounted for only ~20% of the total LDCVs
observed. Trajectories were more linear in axons than
in growth cones, reflecting the influence of axonal
Figure 6 Secretagogues differentially affect instantaneous velocity and direction. Instantaneous velocity and direction were calculated for
tracked LDCVs in neurons kept under basal conditions or exposed to PMA or KCl for 5 min. LDCVs moving in the retrograde direction were
assigned a negative sign, and those moving in the anterograde direction received a positive sign (A); the distribution of binned data is shown
for representative cells from each treatment group. The fraction of LDCVs stopped or moving in a given direction (B) is plotted as an average;
the relationship between direction and velocity was also analyzed (C). One-way ANOVA with Bonferroni post-test (SPSS package): *, p < 0.02;
**, p < 0.01.
Figure 7 PMA increases LDCV pausing time in axons. The effect
of secretagogue on the percentage of time that LDCVs in axons
spent paused was calculated; to be categorized as 0% paused, a
LDCV had to be in continuous motion. The distribution of binned
data is shown.
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Page 10 of 15geometry. We focused our analysis on the distal segments
of axons, the region immediately preceding a growth cone.
To our surprise, under basal conditions, LDCVs in this
region were slightly more likely to move back toward the
cell soma than into the adjacent growth cone.
Differential regulation of dynamics by secretagogues
The most significant effect of secretagogue on average
LDCV dynamics was its effect on trajectory linearity.
Both PMA and KCl stimulation resulted in more linear
LDCV paths in axons, suggestive of motor proteins stay-
ing attached longer. The average velocity of transported
LDCVs was unaffected by stimulation with KCl or
PMA, consistent with the lack of effect of KCl on
orphanin FQ containing LDCV velocity in NS20Y cells
[12]. Average LDCV velocities in trigeminal ganglion
neurons and NS20Y cells were in the same range. Aver-
age LDCV translocation rates for orphanin-GFP LDCVs
in NS20Y cells were increased by forskolin, which
increases intracellular cAMP by activating adenylate
cyclase [12]. In PC12 cells, Ba
2+ stimulation increased
the mobility of the subset of atrial natriuretic factor-
GFP LDCVs located immediately adjacent to the plasma
membrane, suggesting that the releasable pool might be
expanded by making more LDCVs available to refill it
[33]. Mobilization of LDCVs containing ANF-GFP, as
detected by fluorescence recovery after photobleaching,
was observed following depolarization, while no recovery
of bouton fluorescence was observed without stimula-
tion [13]. This liberation was proposed to facilitate
replacement of secreted LDCVs, perhaps by allowing
directed movement of mobilized LDCVs to other term-
inals to be recruited for exocytosis. In chromaffin cells,
PMA limited the mobility of LDCVs in the evanescent
field, and long-range motions were abolished [31].
These authors concluded that PMA increased priming,
but not docking, of LDCVs; a similar phenotype was
observed by overexpressing the priming factor Munc13-
1 [31]. Using wide-field imaging, Shakiryanova et al. cor-
related a decrease in retrograde transport with an
increase in synaptic neuropeptide stores at the Droso-
phila neuromuscular junction following depletion [14].
They concluded that nerve terminals do not wait pas-
sively for new LDCVs to be synthesized and transported
from the soma; rather, the “mismatch” between arrival
and replacement that occurs under basal conditions is
the source of replenishment for the releasable pool dur-
ing activity [14].
Our spinning-disk confocal microscopy approach
allows us to look over a prolonged observation time and
to track LDCVs that move up and down with respect to
the dish surface, as they traverse the axon. Our average
LDCV velocity measurements included 7 to over 30
images (10 to 50 seconds of tracking). The fact that
LDCVs paused and then began to move again is not
reflected in these average velocity measurements. Since
Figure 8 LDCV secretion occurs throughout neurons. Neurons were transfected with vector encoding PAM-GFP. After 2 days in culture, cells
were stimulated with PMA in the presence of PAM ectodomain antibody for 15 min; internalized antibody was subsequently visualized in fixed,
permeabilized cells with a Cy3 conjugated secondary antibody. Internalized PAM antibody was detected throughout the cell soma (top), along
processes (bottom) and at growth cones (labeled). In the absence of secretagogue, almost no antibody uptake was observed (not shown).
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be secreted, we quantified the movements made by each
LDCV from one image to the image taken 1.7 seconds
later; these are designated instantaneous velocities and
include all LDCVs anywhere within the region of inter-
est. LDCVs whose centers remained in the same pixel
were scored as paused. Secretion of LDCV content
would result in diminution or complete loss of signal
and termination of that track. Both partial secretion of a
docked LDCV, which has been shown to occur [13,14],
and loss of motor proteins would be scored as pausing.
Although it has been proposed that stopping or pausing
before secretion is very brief and might be missed [34],
most investigators argue that LDCVs stop for more than
2 sec before secretion, with the majority of LDCVs
stopped for over 15 sec before secretion [30].
Figure 9 Fusion events are detected by increases in PHM-pHluorin fluorescence. Neurons were co-transfected with vectors encoding PHM-
pHluorin and DsRed. All images in this figure are from a single microscope field of one neuron; four other neurons yielded similar results. After 2
days in culture, growth cones of neurons expressing DsRed were identified, and image frames were acquired under basal conditions (A, top left).
A horizontally oriented line was placed through the center of the axon and growth cone. Scans were acquired continuously along the indicated
line during PMA stimulation; two examples are shown (C, left and middle). Distance in the x dimension is represented on the x-axis, with the cell
soma out of the picture to the left and the growth cone to the right. Time is represented on the y-axis; the total time for each image displayed
is 6 sec. At the conclusion of the experiment, the total LDCV population was visualized by adding 5 mM NH4Cl to the bath solution; a frame (B,
right) and line scan (C, right) are shown.
Sobota et al. BMC Neuroscience 2010, 11:32
http://www.biomedcentral.com/1471-2202/11/32
Page 12 of 15When we analyzed the effects of PMA and KCl on
instantaneous direction and velocity, significant differ-
ences were observed. KCl both increased the fraction of
LDCVs undergoing anterograde transport and decreased
the fraction undergoing retrograde transport. PMA did
not alter the anterograde/retrograde distribution of
LDCVs. Interestingly, KCl but not PMA increased
instantaneous velocity in the retrograde direction, while
both KCl and PMA decreased instantaneous velocity in
the anterograde direction. Neuropeptides stored in the
en passant terminals of Drosophila motorneurons are
replenished via capture of retrogradely transiting
LDCVs, not by arrival of LDCVs from the soma [14].
These differences in the effects of KCl and PMA on
LDCV directionality and velocity suggest differences in
the downstream targets of the signaling pathways trig-
gered by these two secretagogues. These observations
also suggest that LDCV transport is less like a unidirec-
tional voyage, and more like sightseeing or commuting.
Most LDCVs were found to travel less than 0.2 μm/
sec. Fast axonal transport is typically defined as microtu-
bule-kinesin-dynein dependent movement at 20 mm/d
or faster (0.2-4.5 μm/sec), and slower transport within
axons has long been recognized to be bidirectional [35].
We found that LDCV movements faster than 0.05 μm/
sec were eliminated by the actin depolymerizing drug
cytochalasin (Figure 4). There is quite a large range of
top speeds reported for LDCV movements, from 0.1 to
over 2.0 μm/sec [11,14,36]. Some studies reporting faster
velocities used differential interference contrast optics,
noting that the fastest objects could be mitochondria,
lysosomes or phagosomes while stationary or slowly
moving objects would not be tracked at all [37]. LDCV
speeds and microtubule sliding velocities are usually
similar, ranging from 0.1-0.3 μm/sec [38-40]. Any
LDCV moving more than 4 pixels (0.68 μm) in 1.7 sec
would be considered lost (or secreted) by the tracking
program (>0.4 μm/sec). Since secretion events for pep-
tides typically take 1-2 seconds (Figure 9 and literature),
the tracking software would define that as the end of a
track. Given the large number of LDCVs in the axons,
the small size of the LDCVs, and the extent to which
the axons move in the Z-axis toward and away from the
focal plane of the dish surface, we could not resolve
LDCVs adequately by epifluorescence and needed the
confocal quality of the images.
Nonsynaptic localization of release sites in neurons
The vast majority of previous studies of LDCV dynamics
and exocytosis utilized neuroendocrine cell lines as
model systems, and nearly all were performed at room
temperature. This has included chromaffin cells, which
are unpolarized [26,31,36,41], and PC12 cells, which
may be differentiated by NGF to extend short neuronal-
like processes which accumulate LDCVs at their endings
[33]. More recent work used developing hippocampal
neurons to analyze motions of LDCVs containing tPA-
EGFP; these were found to be highly mobile in growth
cones and participate in exocytosis at this location with
a slow onset after stimulation [11]. Further studies
demonstrated that this fusion protein was localized to
dendrites and dendritic spines [42]. LDCVs in spines
were found to be immobile under both basal and stimu-
lated conditions, and partial release of the tPA-GFP
fusion protein from these LDCVs occurred over an
extended period of time. One possibility is that retention
of LDCVs and their peptide contents within spines may
be a way to regulate the quantity of neuropeptide
released, and also provide a potential mechanism to pre-
vent depletion of peptide transmitters at postsynaptic
sites [42]. In hippocampal neuronal cultures, secretion
from cell bodies can be 50-times higher than from
axons, based on total internal reflection microscopy [43].
Our findings that LDCVs containing PAM-GFP or
PHM-pHluorin undergo fusion along axons as well as at
growth cone/endings in trigeminal ganglion neurons are
consistent with a role for non-synaptic peptide release.
In fact, a plausible interpretation of Figures 2 and 8
together (8% secretion in 15 min yet a majority of
LDCVs showing internalized antibody) is that partial
release of LDCV content is more common than full
fusion; with full fusion and 8% secretion, one would
expect to see only a small number of yellow LDCVs
after 15 min of antibody uptake. This may be particu-
larly relevant to the normal physiology of the dorsal
root and trigeminal ganglia, in which peptides such as
CGRP and substance P participate in both transmission
of sensory information from the periphery [44], as well
as in peripheral effector functions such as neurogenic
vasodilation [45]. The peripheral axons of the sensory
neurons do not make synaptic contacts, yet secretion of
peptides is known to contribute to local inflammatory
processes. Based on our cell culture data showing 15%
of PHM-GFP released in 30 min, plus PAM antibody
internalization all along the axon at a level comparable
to the growth cone, it seems apparent that exocytosis
must occur along the length of the axon as well, perhaps
serving an autoregulatory or feedback function. Whether
this occurs in vivo has yet to be determined. It will be
interesting in the future to correlate activity- dependent
LDCV dynamics and secretion with physiological
functions.
Conclusions
In the peptidergic neurons of the trigeminal ganglion,
LDCVs are transported away from the cell soma (ante-
rograde) at a significantly faster rate than those traveling
towards the cell soma (retrograde) under basal
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Page 13 of 15conditions. Anterograde LDCV velocity is slowed follow-
ing depolarization by KCl or stimulation with PMA;
both methods of stimulation increase granule pausing
and LDCV exocytosis. Consistent with this, secretagogue
s t i m u l a t e st h eu p t a k eo fa n t i b o d yt h a tr e c o g n i z e st h e
luminal domain of a LDCV membrane protein and also
stimulates the distributed appearance of a pHluorin-
tagged LDCV content protein along the axon.
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